Search research articles
Contact Us
Filters
Showing results (61-70 of 123) with videos related to
Page
of 13
Sort By:
International Journal of Systematic and Evolutionary Microbiology
|
July 24, 2009
Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic species
Jakko van Ingen, Jerome A Lindeboom, Nico G Hartwig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 7, 2011
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Jakko van Ingen, Rob E Aarnoutse, Peter R Donald, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 21, 2010
[Nontuberculous mycobacteria: clinically relevant]
Jakko van Ingen, Wouter Hoefsloot, Wiel C M de Lange, et al.
Tropical Medicine & International Health : TM & IH
|
October 25, 2007
Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid
Gibson S Kibiki, Bert Mulder, Andre J A M van der Ven, et al.
The Lancet. Infectious Diseases
|
July 30, 2011
XDR tuberculosis
Jakko van Ingen, Wiel Cm de Lange, Martin J Boeree, et al.
Emerging Infectious Diseases
|
February 6, 2009
Clinical relevance of nontuberculous Mycobacteria, Oman
Sara H Al-Mahruqi, Jakko van-Ingen, Suleiman Al-Busaidy, et al.
International Journal of Mycobacteriology
|
January 21, 2016
Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing
Rianne J C van der Zanden, Cecile Magis-Escurra, Wiel C M de Lange, et al.
International Journal of Systematic and Evolutionary Microbiology
|
July 20, 2010
Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species
Jakko van Ingen, Enrico Tortoli, Rangaraj Selvarangan, et al.
The Journal of Infectious Diseases
|
May 3, 2018
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations
Robin J Svensson, Elin M Svensson, Rob E Aarnoutse, et al.
Frontiers in Antibiotics
|
April 24, 2026
Simultaneous measurement of 16S-rRNA and pre-16S-rRNA as a strategy to monitor clinical tuberculosis
Evelin Dombay, Wilber Sabiiti, Daniela Alferes de Lima Headley, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 123) with videos related to
Sort By:
Page
of 13
International Journal of Systematic and Evolutionary Microbiology
|
July 24, 2009
Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic species
Jakko van Ingen, Jerome A Lindeboom, Nico G Hartwig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 7, 2011
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Jakko van Ingen, Rob E Aarnoutse, Peter R Donald, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 21, 2010
[Nontuberculous mycobacteria: clinically relevant]
Jakko van Ingen, Wouter Hoefsloot, Wiel C M de Lange, et al.
Tropical Medicine & International Health : TM & IH
|
October 25, 2007
Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid
Gibson S Kibiki, Bert Mulder, Andre J A M van der Ven, et al.
The Lancet. Infectious Diseases
|
July 30, 2011
XDR tuberculosis
Jakko van Ingen, Wiel Cm de Lange, Martin J Boeree, et al.
Emerging Infectious Diseases
|
February 6, 2009
Clinical relevance of nontuberculous Mycobacteria, Oman
Sara H Al-Mahruqi, Jakko van-Ingen, Suleiman Al-Busaidy, et al.
International Journal of Mycobacteriology
|
January 21, 2016
Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing
Rianne J C van der Zanden, Cecile Magis-Escurra, Wiel C M de Lange, et al.
International Journal of Systematic and Evolutionary Microbiology
|
July 20, 2010
Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species
Jakko van Ingen, Enrico Tortoli, Rangaraj Selvarangan, et al.
The Journal of Infectious Diseases
|
May 3, 2018
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations
Robin J Svensson, Elin M Svensson, Rob E Aarnoutse, et al.
Frontiers in Antibiotics
|
April 24, 2026
Simultaneous measurement of 16S-rRNA and pre-16S-rRNA as a strategy to monitor clinical tuberculosis
Evelin Dombay, Wilber Sabiiti, Daniela Alferes de Lima Headley, et al.
Page
of 13